Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
43.31B | 44.55B | 40.98B | 41.95B | 41.68B | 41.17B | Gross Profit |
33.96B | 34.77B | 32.43B | 33.17B | 31.88B | 29.91B | EBIT |
17.43B | 18.04B | 17.04B | 19.03B | 17.17B | 15.07B | EBITDA |
19.15B | 20.62B | 19.27B | 21.09B | 19.04B | 16.87B | Net Income Common Stockholders |
12.08B | 12.33B | 11.64B | 13.40B | 12.16B | 10.96B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
97.41B | 100.57B | 89.85B | 80.14B | 67.15B | 56.01B | Total Assets |
117.38B | 121.04B | 109.10B | 99.46B | 86.22B | 75.40B | Total Debt |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Net Debt |
-87.41B | -90.57B | -84.85B | -73.14B | -62.15B | -56.01B | Total Liabilities |
14.84B | 16.01B | 15.10B | 15.78B | 14.92B | 14.33B | Stockholders Equity |
102.53B | 105.03B | 94.00B | 83.68B | 71.30B | 61.07B |
Cash Flow | Free Cash Flow | ||||
0.00 | 14.98B | 10.53B | 14.31B | 12.12B | 11.16B | Operating Cash Flow |
0.00 | 15.02B | 13.05B | 16.80B | 14.08B | 12.99B | Investing Cash Flow |
0.00 | -27.13B | -8.56B | -3.85B | -2.02B | -3.82B | Financing Cash Flow |
0.00 | -1.28B | -1.28B | -1.03B | -1.03B | -641.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥66.66B | 15.81 | 2.35% | 24.55% | 83.97% | ||
73 Outperform | ¥225.75B | 18.31 | 0.57% | 4.47% | -1.74% | ||
62 Neutral | $11.97B | 10.29 | -7.47% | 2.99% | 7.32% | -8.06% | |
€638.72M | 36.06 | 8.67% | ― | ― | ― | ||
75 Outperform | ¥153.36B | 52.63 | 0.14% | 27.60% | 165.28% | ||
63 Neutral | ¥67.27B | 21.69 | 1.49% | 7.54% | 3.48% | ||
61 Neutral | ¥153.32B | 50.98 | 0.10% | 43.92% | 302.88% |